Open Access125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
Author(s) -
Penghui Hu,
Lan-hong Pan,
P. T. T. Wong,
Wenhui Chen,
Yanqing Yang,
Hong Wang,
Xiang Jin,
Meng Xu
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i21.5033
Subject(s) - basic fibroblast growth factor , monoclonal antibody , microbiology and biotechnology , growth factor , chemistry , vascular endothelial growth factor , biology , antibody , receptor , immunology , biochemistry , cancer research , vegf receptors
To investigate the inhibitory efficacy of (125)I-labeled anti-basic fibroblast growth factor (bFGF) monoclonal antibody (mAb) in hepatocellular carcinoma (HCC).